Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

11-Apr-2007

  • PSA doubling time and indicator of recurrent prostate cancer (News-Medical-Net)

    A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy.


  • Identifying Osteoporosis In Men With Prostate Cancer (Science Daily)

    Measuring a man's daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to a recent study.


  • Prostate cancer: Treatments differ (Pioneer Press)

    The question: Men diagnosed with prostate cancer have three treatment choices: radiation, surgery to remove the prostate gland or 'watchful waiting' - doing nothing unless symptoms worsen. Might one of these options offer a man with aggressive or high-grade cancer the likelihood of living longer?


  • Prostate treatment choices will affect longevity (The Daily News)

    THE QUESTION Men diagnosed with prostate cancer have three basic treatment choices: radiation, surgery to remove the prostate gland or "watchful waiting" -- doing nothing unless symptoms worsen. Might one of these options offer a man with aggressive or high-grade cancer the likelihood of living longer?


  • PSA Doubling Predicts Prostate Cancer Recurrence (Science Daily)

    A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. ...


  • Back to Prostate News Archive